SCHEMBL3050101

SCHEMBL3050101

COc1cc(-c2cc3cc(CNC4CCCCC4)ccc3[nH]2)c2c(c1OS(C)(=O)=O)CNC2=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.40
HTT P42858 3/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 2/20 0.40
GAA P10253 1/20 0.40
ALOX15 P16050 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
HSD17B10 Q99714 1/20 0.40
AURKA O14965 4/20 0.39
KDR P35968 4/20 0.39
POLB P06746 1/20 0.37
PARP1 P09874 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
PKM P14618 1/20 0.35
CHEK1 O14757 1/20 0.34
MITF O75030 1/20 0.34
KCNH2 Q12809 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3039874 0.96 AURKA (0.40) SMN1; SMN2HTTKDM4EALDH1A1HPGD
Hydrochloric Acid SCHEMBL3044160 0.95 AURKA (0.40) SMN1; SMN2HTTKDM4EALDH1A1HPGD
Hydrochloric Acid SCHEMBL3051428 0.88 AURKA (0.37) SMN1; SMN2HTTKDM4EALDH1A1GAA
SCHEMBL3054784 0.88 AURKA (0.42) SMN1; SMN2HTTKDM4EALDH1A1HPGD
Hydrochloric Acid SCHEMBL3049611 0.87 HTT (0.39) SMN1; SMN2HTTKDM4EALDH1A1HPGD
Hydrochloric Acid SCHEMBL3043478 0.87 AURKA (0.42) SMN1; SMN2HTTKDM4EALDH1A1HPGD
Hydrochloric Acid SCHEMBL3047330 0.87 AURKA (0.40) SMN1; SMN2HTTKDM4EALDH1A1HSD17B10
SCHEMBL3049157 0.86 AURKA (0.41) SMN1; SMN2HTTKDM4EALDH1A1AURKA
Hydrochloric Acid SCHEMBL3039578 0.86 AURKA (0.41) SMN1; SMN2HTTKDM4EALDH1A1AURKA
SCHEMBL3047838 0.85 AURKA (0.40) SMN1; SMN2HTTKDM4EALDH1A1AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745641-B2 Nitrogen-containing heterocyclic compound KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-06-29 US claimed
US-7745641-B2 Nitrogen-containing heterocyclic compound KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-06-29 US disclosed
US-20090054407-A1 Nitrogen-containing heterocyclic compound KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed
EP-1880993-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND KYOWA HAKKO KOGYO CO., LTD. (JP) 2008-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054407-A1 Nitrogen-containing heterocyclic compound NR4A1, NR5A2, PRMT8 SMN1; SMN2 3395/4885HTT 1717/4885KDM4E 488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.